Creo Medical Group PLC (AIM:CREO) was the topic of discussion when Proactive analyst John Savin caught up with the London studio.
He explains how the maker of a range surgical appliances that negate the need for invasive and traumatic procedures has significantly increased the number of customer hospitals over the past year.
Giving his take on the opportunity, Savin talks about the importance of Creo's direct sales strategy, how it is "absolutely going in the right direction" but why investors need to have patience and be aware that a cash injection to boost sales and marketing could possibly yield big gains.